196 related articles for article (PubMed ID: 30116144)
21. Sex differences following percutaneous coronary intervention or coronary artery bypass surgery for acute myocardial infarction.
Lin DS; Lin YS; Lee JK; Kao HL
Biol Sex Differ; 2022 Apr; 13(1):18. PubMed ID: 35477482
[TBL] [Abstract][Full Text] [Related]
22. Intervention to increase the proportion of acute myocardial infarction or coronary artery bypass graft patients receiving an order for aspirin at hospital discharge.
Brackbill ML; Kline VT; Sytsma CS; Call JT
J Manag Care Pharm; 2010 Jun; 16(5):329-36. PubMed ID: 20518585
[TBL] [Abstract][Full Text] [Related]
23. Systemic levels of endothelin correlate with systemic inflammation and not with myocardial injury or left ventricular ejection fraction in patients undergoing percutaneous coronary intervention and on-pump coronary artery bypass grafting.
Cuculi F; Lim CC; van Gaal W; Testa L; Westaby S; Arnold JR; Neubauer S; Banning AP
Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):585-9. PubMed ID: 21908890
[TBL] [Abstract][Full Text] [Related]
24. Appropriate timing of coronary artery bypass grafting after acute myocardial infarction.
Assmann A; Boeken U; Akhyari P; Lichtenberg A
Thorac Cardiovasc Surg; 2012 Oct; 60(7):446-51. PubMed ID: 22549759
[TBL] [Abstract][Full Text] [Related]
25. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
[No Abstract] [Full Text] [Related]
26. Sustained decrease in plasma sphingosine-1-phosphate concentration and its accumulation in blood cells in acute myocardial infarction.
Knapp M; Lisowska A; Zabielski P; Musiał W; Baranowski M
Prostaglandins Other Lipid Mediat; 2013 Oct; 106():53-61. PubMed ID: 24120760
[TBL] [Abstract][Full Text] [Related]
27. Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.
Serruys PW; Cavalcante R; Collet C; Kappetein AP; Sabik JF; Banning AP; Taggart DP; Sabaté M; Pomar J; Boonstra PW; Lembo NJ; Onuma Y; Simonton CA; Morice MC; McAndrew T; Dressler O; Stone GW
JACC Cardiovasc Interv; 2018 Jul; 11(13):1234-1243. PubMed ID: 29976359
[TBL] [Abstract][Full Text] [Related]
28. HDL-bound sphingosine 1-phosphate (S1P) predicts the severity of coronary artery atherosclerosis.
Sattler K; Lehmann I; Gräler M; Bröcker-Preuss M; Erbel R; Heusch G; Levkau B
Cell Physiol Biochem; 2014; 34(1):172-84. PubMed ID: 24977490
[TBL] [Abstract][Full Text] [Related]
29. Plasma sphingosine-1-phosphate concentration is reduced in patients with myocardial infarction.
Knapp M; Baranowski M; Czarnowski D; Lisowska A; Zabielski P; Górski J; Musiał W
Med Sci Monit; 2009 Sep; 15(9):CR490-3. PubMed ID: 19721401
[TBL] [Abstract][Full Text] [Related]
30. Complement activation in acute myocardial infarction: An early marker of inflammation and tissue injury?
Bavia L; Lidani KCF; Andrade FA; Sobrinho MIAH; Nisihara RM; de Messias-Reason IJ
Immunol Lett; 2018 Aug; 200():18-25. PubMed ID: 29908956
[TBL] [Abstract][Full Text] [Related]
31. The effect of lifestyle modification on depression among myocardial infarction patients after revascularisation.
Arzet A; Sibanda W; Naidoo DP; Somalingum P
Cardiovasc J Afr; 2021 Mar-Apr 23; 32(2):70-77. PubMed ID: 33769428
[TBL] [Abstract][Full Text] [Related]
32. Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat.
Knapp M; Zendzian-Piotrowska M; Błachnio-Zabielska A; Zabielski P; Kurek K; Górski J
Basic Res Cardiol; 2012 Nov; 107(6):294. PubMed ID: 22961594
[TBL] [Abstract][Full Text] [Related]
33. Serum cholesterol, lifestyle, working capacity and quality of life in patients with coronary artery disease. Experiences from a hospital-based secondary prevention programme.
Carlsson R
Scand Cardiovasc J Suppl; 1998; 50():1-20. PubMed ID: 9802147
[TBL] [Abstract][Full Text] [Related]
34. Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
Ben-Yehuda O; Chen S; Redfors B; McAndrew T; Crowley A; Kosmidou I; Kandzari DE; Puskas JD; Morice MC; Taggart DP; Leon MB; Lembo NJ; Brown WM; Simonton CA; Dressler O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
Eur Heart J; 2019 Jun; 40(24):1930-1941. PubMed ID: 30919909
[TBL] [Abstract][Full Text] [Related]
35. Comparison of outcomes of patients with ST-segment elevation myocardial infarction with versus without previous coronary artery bypass grafting (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial).
Nikolsky E; Mehran R; Yu J; Witzenbichler B; Brodie BR; Kornowski R; Brener S; Xu K; Dangas GD; Stone GW
Am J Cardiol; 2013 May; 111(10):1377-86. PubMed ID: 23465098
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.
Mäkikallio T; Holm NR; Lindsay M; Spence MS; Erglis A; Menown IB; Trovik T; Eskola M; Romppanen H; Kellerth T; Ravkilde J; Jensen LO; Kalinauskas G; Linder RB; Pentikainen M; Hervold A; Banning A; Zaman A; Cotton J; Eriksen E; Margus S; Sørensen HT; Nielsen PH; Niemelä M; Kervinen K; Lassen JF; Maeng M; Oldroyd K; Berg G; Walsh SJ; Hanratty CG; Kumsars I; Stradins P; Steigen TK; Fröbert O; Graham AN; Endresen PC; Corbascio M; Kajander O; Trivedi U; Hartikainen J; Anttila V; Hildick-Smith D; Thuesen L; Christiansen EH;
Lancet; 2016 Dec; 388(10061):2743-2752. PubMed ID: 27810312
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Percutaneous Coronary Intervention, Coronary Artery Bypass Grafting and Medical Therapy in Non-ST Elevation Acute Coronary Syndrome Patients With 3-Vessel Disease.
Jia S; Zhang C; Jiang L; Xu L; Tian J; Zhao X; Feng X; Wang D; Zhang Y; Sun K; Xu J; Liu R; Xu B; Zhao W; Hui R; Gao R; Gao Z; Yuan J; Song L
Circ J; 2020 Sep; 84(10):1718-1727. PubMed ID: 32848116
[TBL] [Abstract][Full Text] [Related]
38. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
[TBL] [Abstract][Full Text] [Related]
39. Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization.
Gregson J; Stone GW; Ben-Yehuda O; Redfors B; Kandzari DE; Morice MC; Leon MB; Kosmidou I; Lembo NJ; Brown WM; Karmpaliotis D; Banning AP; Pomar J; Sabaté M; Simonton CA; Dressler O; Kappetein AP; Sabik JF; Serruys PW; Pocock SJ
J Am Coll Cardiol; 2020 Oct; 76(14):1609-1621. PubMed ID: 33004126
[TBL] [Abstract][Full Text] [Related]
40. [Effects of hemoglobin level on the risk of acute kidney injury in patients with acute myocardial infarction].
Sun L; Chi B; Mao L; Zou A; Wang Q; Jiang J; Ji Y; Zhou X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Dec; 34(12):1243-1247. PubMed ID: 36567576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
